The SR11302 inhibit Fra-1/AP-1 binding to TRE site showed significantly suppression in tumor growth and lymph node metastasis of head and neck squamous cell carcinoma (HNSCC) (Figure 2D) (80). Here, JUND is linked to neoplasm.